The Epilepsy Research Foundation Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2009
NCT00894010
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

carbamazepine (tegretol) (1 trial)

levetiracetam (keppra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Epilepsy (Phase 2)

Epilepsy, Reflex (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2